Trending Stock News

Cvs Health (CVS) Share Price Declined While Lvm Capital Management LTD Has Decreased Its Holding; Team (TISI) Position Raised by Horrell Capital Management Inc

CVS Health Corporation (NYSE:CVS) Logo

Lvm Capital Management Ltd decreased its stake in Cvs Health (CVS) by 95.95% based on its latest 2017Q4 regulatory filing with the SEC. Lvm Capital Management Ltd sold 106,924 shares as the company’s stock declined 17.45% with the market. The institutional investor held 4,510 shares of the medical and nursing services company at the end of 2017Q4, valued at $327,000, down from 111,434 at the end of the previous reported quarter. Lvm Capital Management Ltd who had been investing in Cvs Health for a number of months, seems to be less bullish one the $67.12B market cap company. The stock increased 4.21% or $2.67 during the last trading session, reaching $66.1. About 19.01M shares traded or 120.33% up from the average. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 17, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Horrell Capital Management Inc increased its stake in Team Incorporated (TISI) by 49.57% based on its latest 2017Q4 regulatory filing with the SEC. Horrell Capital Management Inc bought 75,000 shares as the company’s stock declined 5.88% with the market. The institutional investor held 226,300 shares of the consumer services company at the end of 2017Q4, valued at $3.37 million, up from 151,300 at the end of the previous reported quarter. Horrell Capital Management Inc who had been investing in Team Incorporated for a number of months, seems to be bullish on the $503.79 million market cap company. The stock increased 1.51% or $0.25 during the last trading session, reaching $16.8. About 442,144 shares traded. Team, Inc. (NYSE:TISI) has declined 46.03% since April 17, 2017 and is downtrending. It has underperformed by 57.58% the S&P500.

Since December 15, 2017, it had 2 insider purchases, and 0 insider sales for $82,521 activity. Shares for $52,649 were bought by Davis Jeffery Gerald.

Horrell Capital Management Inc, which manages about $297.04 million and $191.20 million US Long portfolio, decreased its stake in Syntel (NASDAQ:SYNT) by 50,800 shares to 100,000 shares, valued at $2.30 million in 2017Q4, according to the filing. It also reduced its holding in O’reilly Automotive Inc (NASDAQ:ORLY) by 8,000 shares in the quarter, leaving it with 20,070 shares, and cut its stake in Cray Inc (NASDAQ:CRAY).

Investors sentiment decreased to 1.1 in 2017 Q4. Its down 0.97, from 2.07 in 2017Q3. It turned negative, as 16 investors sold TISI shares while 46 reduced holdings. 28 funds opened positions while 40 raised stakes. 33.82 million shares or 3.37% more from 32.72 million shares in 2017Q3 were reported. Royal Financial Bank Of Canada owns 1.46M shares. First Eagle Inv Limited Liability Corporation holds 0% or 75,000 shares in its portfolio. Benjamin F Edwards & owns 100 shares. State Street accumulated 0% or 727,126 shares. Bnp Paribas Arbitrage holds 0% in Team, Inc. (NYSE:TISI) or 12,445 shares. Susquehanna Gp Llp holds 0% or 11,903 shares in its portfolio. Dimensional Fund Advisors Lp invested in 0.01% or 2.19M shares. Engineers Gate Manager Ltd Partnership holds 47,010 shares or 0.05% of its portfolio. Invesco Limited holds 0.01% or 2.06M shares in its portfolio. Skylands Ltd Liability Company accumulated 70,500 shares or 0.14% of the stock. 858 were accumulated by Ls Invest Advsrs Ltd Liability Company. Barrow Hanley Mewhinney & Strauss Limited Liability has 0% invested in Team, Inc. (NYSE:TISI). Proxima holds 3.81% of its portfolio in Team, Inc. (NYSE:TISI) for 441,200 shares. New York State Common Retirement Fund, a New York-based fund reported 87,803 shares. Td Asset owns 0% invested in Team, Inc. (NYSE:TISI) for 20,600 shares.

Among 4 analysts covering Team (NYSE:TISI), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Team had 8 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was upgraded by Johnson Rice to “Accumulate” on Wednesday, November 8. On Tuesday, January 23 the stock rating was upgraded by Johnson Rice to “Buy”. The firm has “Buy” rating given on Monday, January 22 by Stephens. The company was upgraded on Monday, October 5 by Johnson Rice. On Wednesday, August 12 the stock rating was upgraded by Zacks to “Hold”. KeyBanc Capital Markets maintained the shares of TISI in report on Monday, September 18 with “Buy” rating. KeyBanc Capital Markets maintained Team, Inc. (NYSE:TISI) rating on Friday, February 9. KeyBanc Capital Markets has “Overweight” rating and $19 target. On Thursday, January 7 the stock rating was downgraded by BB&T Capital to “Hold”.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It dived, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Cibc has invested 0.16% of its portfolio in CVS Health Corporation (NYSE:CVS). Loudon Invest Management Ltd Llc invested 0.46% of its portfolio in CVS Health Corporation (NYSE:CVS). Moreover, Valicenti Advisory Service has 1.41% invested in CVS Health Corporation (NYSE:CVS). Banque Pictet Cie owns 28,047 shares for 0.04% of their portfolio. Gotham Asset Mgmt Ltd Llc holds 951,796 shares. Captrust Fincl Advsr reported 0.36% stake. Brown Advisory holds 0.05% or 220,337 shares in its portfolio. Texas-based Mcdaniel Terry has invested 1.75% in CVS Health Corporation (NYSE:CVS). Cambridge Inv Research Advsrs Inc holds 0.1% or 119,788 shares. 77,592 are owned by Bank & Trust Of The West. Crestwood Advsr Grp Ltd Limited Liability Company reported 198,433 shares or 1.14% of all its holdings. First Natl Tru holds 0.14% of its portfolio in CVS Health Corporation (NYSE:CVS) for 17,270 shares. Cap holds 2.15M shares. Hayek Kallen Investment Mgmt has 0.68% invested in CVS Health Corporation (NYSE:CVS) for 14,335 shares. Public Employees Retirement Association Of Colorado reported 192,948 shares.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 75 analyst reports since July 22, 2015 according to SRatingsIntel. Morgan Stanley upgraded CVS Health Corporation (NYSE:CVS) on Friday, January 5 to “Overweight” rating. The stock has “Hold” rating by Robert W. Baird on Thursday, January 4. JP Morgan maintained CVS Health Corporation (NYSE:CVS) on Monday, November 2 with “Overweight” rating. Mizuho maintained the shares of CVS in report on Wednesday, November 9 with “Buy” rating. On Friday, September 8 the stock rating was maintained by Needham with “Hold”. The rating was maintained by Jefferies with “Hold” on Wednesday, October 18. The firm earned “Neutral” rating on Monday, May 9 by Citigroup. On Thursday, June 23 the stock rating was maintained by Mizuho with “Buy”. Vetr upgraded the stock to “Buy” rating in Monday, August 24 report. The stock has “Hold” rating by Robert W. Baird on Monday, September 25.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *